The objective of this systematic literature review was to determine the association between
cardiovascular events (CVEs) and antirheumatic drugs in rheumatoid arthritis (RA) and …

Objective. Comorbidities such as cardiovascular diseases (CVD), cancer, osteoporosis, and
depression are often underrecognized in patients with rheumatoid arthritis (RA), psoriatic …

Background: Smoking has been associated with psoriasis prevalence and severity.
Objective: To evaluate prevalence of smoking in patients with psoriasis and to examine the …

Objective To examine the impact of antirheumatic drugs on bone mineral density (BMD) in
rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), and psoriasis …

Introduction Psoriatic arthritis (PsA) and spondyloarthritis (SpA) are inflammatory arthritides
associated with progressive damage, deformity and morbidity. Janus kinase (JAK) inhibitors …

Objective. To develop recommendations for the assessment of people with systemic lupus
erythematosus (SLE) in Canada. Methods. Recommendations were developed using the …

Objective. Nontraumatic osteonecrosis (ON) is a well-recognized complication causing disability
and affecting quality of life in patients with systemic lupus erythematosus (SLE). The aim …

Objective Cardiovascular disease (CVD) is a leading cause of mortality in rheumatoid arthritis
(RA). This study systematically reviewed and appraised guidelines and quality indicators (…

Objective. Patients with rheumatoid arthritis (RA) have a high risk of premature cardiovascular
disease (CVD). We developed CVD quality indicators (QI) for screening and use in …

Objective. The effects of rheumatoid arthritis (RA) and spondyloarthritis (SpA) on maternal
and neonatal outcomes at a population level have not previously been well compared. …